Total Payments
$67,728
2024 Payments
$27,360
Companies
19
Transactions
129
Medicare Patients
2,566
Medicare Billing
$433,714
Payment Breakdown by Category
Other$45,000 (66.4%)
Travel$8,525 (12.6%)
Consulting$8,338 (12.3%)
Food & Beverage$5,827 (8.6%)
Education$37.83 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,000 | 17 | 66.4% |
| Travel and Lodging | $8,525 | 13 | 12.6% |
| Consulting Fee | $8,338 | 2 | 12.3% |
| Food and Beverage | $5,827 | 92 | 8.6% |
| Education | $37.83 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $46,933 | 56 | $0 (2024) |
| PFIZER INC. | $8,024 | 13 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $5,138 | 6 | $0 (2023) |
| Lilly USA, LLC | $3,856 | 4 | $0 (2024) |
| Celgene Corporation | $1,421 | 11 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $558.37 | 8 | $0 (2024) |
| Allergan Inc. | $377.10 | 10 | $0 (2019) |
| Covidien LP | $238.81 | 3 | $0 (2019) |
| Medtronic, Inc. | $233.28 | 4 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $171.87 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,360 | 33 | ABBVIE INC. ($23,142) |
| 2023 | $29,426 | 30 | ABBVIE INC. ($23,232) |
| 2022 | $721.37 | 16 | ABBVIE INC. ($284.08) |
| 2021 | $8,025 | 11 | PFIZER INC. ($7,579) |
| 2019 | $1,210 | 22 | PFIZER INC. ($445.19) |
| 2018 | $748.04 | 14 | Allergan Inc. ($245.95) |
| 2017 | $238.39 | 3 | Janssen Scientific Affairs, LLC ($124.80) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $104.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $94.07 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $44.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $120.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $55.23 | General |
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $79.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Gastroenterology | ||||||
| 10/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 06/06/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,562.50 | General |
| 06/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $132.25 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $54.92 | General |
| Category: IMMUNOLOGY | ||||||
| 06/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $99.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Travel and Lodging | In-kind items and services | $599.72 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Travel and Lodging | In-kind items and services | $215.46 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Travel and Lodging | In-kind items and services | $129.45 | General |
| Category: IMMUNOLOGY | ||||||
| 04/08/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 564 | 595 | $259,117 | $56,206 |
| 2022 | 16 | 656 | 1,905 | $388,668 | $97,197 |
| 2021 | 18 | 749 | 7,887 | $600,848 | $216,807 |
| 2020 | 15 | 597 | 665 | $214,449 | $63,504 |
Total Patients
2,566
Total Services
11,052
Medicare Billing
$433,714
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 73 | 74 | $70,764 | $14,604 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 115 | $19,650 | $10,348 | 52.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 68 | 69 | $18,915 | $6,898 | 36.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 76 | 77 | $46,665 | $5,868 | 12.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 79 | 80 | $63,523 | $4,949 | 7.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 78 | $13,565 | $4,654 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $6,435 | $2,482 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 37 | $4,820 | $2,205 | 45.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $4,700 | $2,170 | 46.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $7,185 | $1,184 | 16.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $2,895 | $843.70 | 29.1% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 12 | 1,200 | $132,000 | $34,714 | 26.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 66 | 66 | $62,894 | $12,436 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 113 | $17,665 | $10,263 | 58.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 82 | 83 | $20,595 | $8,715 | 42.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 88 | 102 | $16,060 | $5,374 | 33.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 67 | 71 | $39,150 | $4,934 | 12.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 70 | 70 | $55,564 | $4,806 | 8.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 22 | 34 | $8,500 | $3,319 | 39.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 22 | $4,950 | $2,999 | 60.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,370 | $2,297 | 52.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 24 | 24 | $4,615 | $1,893 | 41.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $8,670 | $1,457 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 27 | $3,130 | $1,407 | 44.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 11 | 11 | $7,150 | $1,311 | 18.3% |
About Dr. Michael Engels, M.D
Dr. Michael Engels, M.D is a Internal Medicine healthcare provider based in Allentown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1598085334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Engels, M.D has received a total of $67,728 in payments from pharmaceutical and medical device companies, with $27,360 received in 2024. These payments were reported across 129 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,000).
As a Medicare-enrolled provider, Engels has provided services to 2,566 Medicare beneficiaries, totaling 11,052 services with total Medicare billing of $433,714. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Allentown, PA
- Active Since 06/03/2010
- Last Updated 05/26/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598085334
Products in Payments
- RINVOQ (Biological) $22,203
- SKYRIZI (Biological) $20,733
- ZEPOSIA (Drug) $6,550
- INFLECTRA (Biological) $5,175
- OMVOH (Drug) $3,856
- ENTYVIO (Biological) $344.91
- XELJANZ (Drug) $324.06
- STELARA (Biological) $171.87
- GATTEX (Drug) $146.03
- Barrx (Device) $124.80
- Trulance (Drug) $124.73
- INTERSTIM (Device) $123.93
- ZENPEP (Drug) $121.72
- LINZESS (Drug) $120.03
- XIFAXAN (Drug) $115.94
- CLENPIQ (Drug) $114.77
- GI Genius (Device) $114.72
- VOWST (Biological) $105.32
- Bravo (Device) $99.97
- ACQUIRE (Device) $96.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Allentown
Shailendra Singh, M.d, M.D
Internal Medicine — Payments: $348,804
Internal Medicine $348,804
Dr. Sabahat Bokhari, M.d, M.D
Internal Medicine — Payments: $324,754
Internal Medicine $324,754
Dr. Orlando Penaloza, M.d, M.D
Internal Medicine — Payments: $135,198
Internal Medicine $135,198
Hiral Shah, Md, MD
Internal Medicine — Payments: $119,608
Internal Medicine $119,608
Elliot Sussman, Md, MD
Internal Medicine — Payments: $114,865
Internal Medicine $114,865
Maria Jones, Md, MD
Internal Medicine — Payments: $82,533
Internal Medicine $82,533